Journal of Clinical Endocrinology & Metabolism, Vol 70, 149-154, Copyright © 1990 by Endocrine Society

ARTICLES

Circulating fibroblast growth factor-like substance in familial multiple endocrine neoplasia type 1

MB Zimering, ML Brandi, DA deGrange, SJ Marx, E Streeten, N Katsumata, PR Murphy, Y Sato, HG Friesen and GD Aurbach
Metabolic Diseases Branch, National Institutes of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892.

Basic fibroblast growth factor (bFGF) is a potent endothelial cell mitogen found in a variety of normal and tumor tissues. Basic FGF lacks a classical signal sequence, and it is not clear how it is released from cells. bFGF or bFGF-like activity has not been previously demonstrated in plasma. In an earlier study we showed increased mitogenic activity for parathyroid-derived epithelial and mesenchymal cells in plasma of subjects with familial multiple endocrine neoplasia type 1 (FMEN1). In the present study we examined the growth-promoting activity of normal and FMEN1 plasmas [applied to heparin-Sepharose (HS) columns] in parathyroid-derived cloned endothelial cells. FMEN1 plasma HS-adsorbed activity exceeded normal plasma HS-adsorbed activity in 6 of 8 FMEN1 plasma samples. Peak (FMEN1 plasma) HS-adsorbed activity eluted with 0.1-0.3 M NaCl, was completely neutralized by specific antibodies against bFGF, and had an apparent mol wt of 110 kD. Active fractions from FMEN1 plasma prepared by gel filtration in 7 M urea displayed apparent mol wt of about 14-16 kD and showed increased apparent affinity for HS; recovered activity appeared principally in the 3.0-M NaCl eluate. Using a sensitive two-site immunoradiometric assay for bFGF we found 0.4 ng/mL bFGF-like immunoreactivity in the highly purified 3.0-M NaCl eluate from a HS column to which the active components from gel filtration of FMEN1 plasma in 7 M urea were applied. These results imply that bFGF or closely related factors circulate in FMEN1.

This article has been cited by other articles:

				N. Garcia de la Torre, I. Buley, J. A. H. Wass, D. G. Jackson, and H. E. Turner Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative Lesions J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2890 - 2896. [Abstract] [Full Text] [PDF]

				T. A. Jackson, R. E. Schweppe, D. M. Koterwas, and A. P. Bradford Fibroblast Growth Factor Activation of the Rat PRL Promoter is Mediated by PKC{delta} Mol. Endocrinol., September 1, 2001; 15(9): 1517 - 1528. [Abstract] [Full Text] [PDF]

				S. Mahr, N. Neumayer, H. J. Kolb, W. Schepp, M. Classen, and C. Prinz Growth Factor Effects on Apoptosis of Rat Gastric Enterochromaffin-Like Cells Endocrinology, October 1, 1998; 139(10): 4380 - 4390. [Abstract] [Full Text] [PDF]

				I. Shimon and S. Melmed Pituitary Tumor Pathogenesis J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1675 - 1681. [Full Text] [PDF]

				D. Ray and S. Melmed Pituitary Cytokine and Growth Factor Expression and Action Endocr. Rev., April 1, 1997; 18(2): 206 - 228. [Abstract] [Full Text]